You are here

Oncology Imaging


New appropriateness criteria created to get patients more involved in their own care have been released today, online in the Journal of the American College of Radiology.

Five years ago the American Society of Clinical Oncology (ASCO) advised clinicians not to order advanced imaging or tumor marker tests for survivors of early-stage breast cancer. Yet the exam orders keep coming.

Reviewing brain MRI of close to 4,000 children as part of an ongoing population-based study, European neuroradiologists and neuroscientists discovered at least one incidental finding in more than one-quarter of the cohort.

The National Academy of Medicine announced Monday, Oct. 17, that it elected 80 new members, including Deborah Watkins Bruner, RN, PhD, a professor of radiation oncology at Emory University in Atlanta. 

A single 90-minute examination designed to assess chemotherapy-induced injuries of the brain, heart and joints among childhood cancer survivors has been proven feasible by a new study.


Recent Headlines

Q&A: What’s the secret to building a successful lung cancer screening team?

How do you take an assortment of individual medical professionals from various disciplines and turn them into a well-oiled lung cancer screening machine? Geoffrey Rubin, MD, details the challenges of building and managing a multidisciplinary team and the overall benefits of effective screening programs on the radiology profession.

Radiotherapy reduces pain from bone metastases but barely lifts quality of life

Radiation treatments help relieve pain from bone metastases, but the alleviation isn’t pronounced enough to improve patients’ overall quality of life, according to a Dutch study posted online March 29 in the International Journal of Radiation Oncology*Biology*Physics.

Have cancer, will travel? The relationship between distance and radiation treatment rates

The distance a patient must travel to receive radiation therapy treatments for rectal cancer plays a significant role in whether he or she ultimately receives treatment, according to results of a study published in a recent issue of the International Journal of Radiation Oncology: Biology-Physics.

Image-guided surveillance reduces unnecessary surgeries for head and neck cancer

Utilization of PET-CT imaging surveillance following chemotherapy treatment for squamous-cell carcinoma of the head and neck can help identify patients requiring further treatment such as neck dissection while also reducing unnecessary surgeries, according to results of a study published online March 24 by the New England Journal of Medicine.

Gene-editing tool could be a breakthrough in fight against cancer, other diseases

Medical science may have just taken a major step toward curing diseases including cancer, autism, HIV and more by manipulating cells using a novel gene-editing tool, according to results of a recent study published in the journal Cell.

Annual screenings add little value to the care of cancer-free heavy smokers

Newly crunched big data show that very few people at high risk for lung cancer from smoking benefit by getting annual low-dose CT screenings after an initial exam brings back negative results, according to a study published online March 21 in The Lancet Oncology. 

Alternative radiotherapy offers less toxic treatment for children with brain tumors

Proton radiotherapy has been shown to achieve results similar to conventional photon radiotherapy while also decreasing toxicity to acceptable levels in pediatric brain tumor patients, according to results of a study published online in Lancet Oncology.

CDC report: Cancer mortality rates steadily declining

The CDC is reporting a consistent decrease in combined cancer death rates as part of its annual Report to the Nation on the Status of Cancer.

Image-guided radiotherapy from Brainlab helps reduce risk to organs in SBRT study

Brainlab, a medical technology company headquartered in Munich, Germany, announced today that its ExTrac Image Guided Radiotherapy treatment was successful in shielding risk organs from toxicity as part of a study investigating the safety and efficacy of stereotactic body radiation therapy (SBRT) in prostate cancer treatment.

Novocure’s Optune receives positive coverage decision from Humana

Novocure, an oncology company based in Portsmouth, N.H., announced today that its portable, noninvasive brain tumor device Optune will now be covered by Humana, which becomes the ninth commercial payer in the U.S. to issue a positive coverage policy for the treatment.